Salmonella typhimurium - Xen33 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the parental strain FDA 1189. S. typhimurium-Xen33 possesses a stable copy of the Photorhabdus luminescens幸运8平台彩票 lux operon on the bacterial chromosome.
For laboratory use only. This product is intended for animal research only and not for use in humans.
幸运8平台彩票Infectious disease is a perennially important area for both life science research and drug discovery. Some of the first applications of IVIS® imaging technology were in tracking infections and monitoring host responses, and these applications are still at the forefront of research. PerkinElmer's bioluminescent infectious disease light-producing microorganisms have been developed to mimic both acute and chronic standard infection protocols presently used by researchers.
Advantages of using bioluminescent light-producing microorganisms for drug discovery in vitro:
Advantages of using bioluminescent light-producing microorganisms for drug discovery in vivo:
|产品尺寸||1 agar plate|